JURJ, A., C. POP-BICA, Ondřej SLABÝ, C. D. STEFAN, W. C. CHO, S. S. KORBAN a I. BERINDAN-NEAGOE. Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer. International Journal of Molecular Sciences. Basel: Multidisciplinary Digital Publishing Institute, 2020, roč. 21, č. 20, s. 1-27. ISSN 1422-0067. Dostupné z: https://dx.doi.org/10.3390/ijms21207688.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer
Autoři JURJ, A. (642 Rumunsko), C. POP-BICA (642 Rumunsko), Ondřej SLABÝ (203 Česká republika, domácí), C. D. STEFAN (702 Singapur), W. C. CHO (156 Čína), S. S. KORBAN (840 Spojené státy) a I. BERINDAN-NEAGOE (642 Rumunsko, garant).
Vydání International Journal of Molecular Sciences, Basel, Multidisciplinary Digital Publishing Institute, 2020, 1422-0067.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10608 Biochemistry and molecular biology
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 5.923
Kód RIV RIV/00216224:14110/20:00117881
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.3390/ijms21207688
UT WoS 000585581600001
Klíčová slova anglicky extracellular vesicles; cancer; therapeutic agents; cell-to-cell communication
Štítky 14110230, podil, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 21. 7. 2021 10:28.
Anotace
Communications among cells can be achieved either via direct interactions or via secretion of soluble factors. The emergence of extracellular vesicles (EVs) as entities that play key roles in cell-to-cell communication offer opportunities in exploring their features for use in therapeutics; i.e., management and treatment of various pathologies, such as those used for cancer. The potential use of EVs as therapeutic agents is attributed not only for their cell membrane-bound components, but also for their cargos, mostly bioactive molecules, wherein the former regulate interactions with a recipient cell while the latter trigger cellular functions/molecular mechanisms of a recipient cell. In this article, we highlight the involvement of EVs in hallmarks of a cancer cell, particularly focusing on those molecular processes that are influenced by EV cargos. Moreover, we explored the roles of RNA species and proteins carried by EVs in eliciting drug resistance phenotypes. Interestingly, engineered EVs have been investigated and proposed as therapeutic agents in various in vivo and in vitro studies, as well as in several clinical trials.
Návaznosti
824036, interní kód MUNázev: Excellence in research and development of non-coding RNA DIAGnostics in ONcology (Akronym: RNADIAGON)
Investor: Evropská unie, Excellence in research and development of non-coding RNA DIAGnostics in ONcology, MSCA Marie Skłodowska-Curie Actions (Excellent Science)
VytisknoutZobrazeno: 13. 5. 2024 20:56